Product nameAnti-TRIM4 antibody - Neuronal Marker
See all TRIM4 primary antibodies
DescriptionRabbit polyclonal to TRIM4 - Neuronal Marker
Tested applicationsSuitable for: IHC-P, WBmore details
Species reactivityReacts with: Human
Synthetic peptide within Human TRIM4 (N terminal) conjugated to keyhole limpet haemocyanin. The exact sequence is proprietary.
Database link: Q9C037
- A549, 293 and HepG2 cell line lysates. Human liver tissue.
Previously labelled as RNF87.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle.
Storage bufferPreservative: 0.09% Sodium azide
Constituent: 99% PBS
Concentration information loading...
PurityImmunogen affinity purified
Purification notesab171613 is purified through a protein A column, followed by peptide affinity purification.
Our Abpromise guarantee covers the use of ab171613 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||1/10 - 1/50. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.|
|WB||1/100 - 1/500. Predicted molecular weight: 57 kDa.|
Sequence similaritiesBelongs to the TRIM/RBCC family.
Contains 1 B box-type zinc finger.
Contains 1 B30.2/SPRY domain.
Contains 1 RING-type zinc finger.
- Information by UniProt
- RING finger protein 87 antibody
- RNF 87 antibody
- RNF87 antibody
Immunohistochemical analysis of formalin fixed and paraffin embedded Human liver tissue labeling TRIM4 at 1/10 dilution, followed by peroxidase conjugation of the secondary antibody and DAB staining
All lanes : Anti-TRIM4 antibody - Neuronal Marker (ab171613) at 1/100 dilution
Lane 1 : A549 cell line lysate
Lane 2 : 293 cell line lysate
Lane 3 : HepG2 cell line lysate
Lysates/proteins at 35 µg per lane.
Developed using the ECL technique.
Predicted band size: 57 kDa
ab171613 has not yet been referenced specifically in any publications.